Market Closed -
Nyse
04:00:13 2024-04-26 pm EDT
|
5-day change
|
1st Jan Change
|
74
USD
|
-2.22%
|
|
-1.53%
|
-0.28%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
26,015
|
34,805
|
48,081
|
46,439
|
39,643
|
39,692
|
-
|
-
|
Enterprise Value (EV)
1 |
27,618
|
40,784
|
53,801
|
52,385
|
40,279
|
41,408
|
38,453
|
35,056
|
P/E ratio
|
20
x
|
19.2
x
|
36.1
x
|
39.6
x
|
15
x
|
12.9
x
|
11.4
x
|
9.76
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
2.25%
|
-
|
Capitalization / Revenue
|
0.35
x
|
0.31
x
|
0.38
x
|
0.32
x
|
0.26
x
|
0.27
x
|
0.27
x
|
0.24
x
|
EV / Revenue
|
0.37
x
|
0.37
x
|
0.43
x
|
0.36
x
|
0.26
x
|
0.28
x
|
0.27
x
|
0.22
x
|
EV / EBITDA
|
9.87
x
|
8.2
x
|
9.8
x
|
11.3
x
|
7.36
x
|
8.94
x
|
7.8
x
|
6.49
x
|
EV / FCF
|
36.7
x
|
8.8
x
|
16.3
x
|
9.96
x
|
5.55
x
|
9.7
x
|
8.85
x
|
8.06
x
|
FCF Yield
|
2.73%
|
11.4%
|
6.12%
|
10%
|
18%
|
10.3%
|
11.3%
|
12.4%
|
Price to Book
|
2.08
x
|
1.35
x
|
1.79
x
|
1.88
x
|
1.53
x
|
1.45
x
|
1.3
x
|
1.2
x
|
Nbr of stocks (in thousands)
|
413,796
|
579,798
|
583,503
|
566,260
|
534,201
|
536,383
|
-
|
-
|
Reference price
2 |
62.87
|
60.03
|
82.40
|
82.01
|
74.21
|
74.00
|
74.00
|
74.00
|
Announcement Date
|
2/4/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
74,639
|
111,115
|
125,982
|
144,547
|
153,999
|
146,832
|
144,368
|
162,210
|
EBITDA
1 |
2,799
|
4,972
|
5,490
|
4,624
|
5,475
|
4,632
|
4,929
|
5,402
|
EBIT
1 |
2,414
|
4,432
|
4,014
|
3,888
|
4,182
|
4,066
|
4,306
|
4,886
|
Operating Margin
|
3.23%
|
3.99%
|
3.19%
|
2.69%
|
2.72%
|
2.77%
|
2.98%
|
3.01%
|
Earnings before Tax (EBT)
1 |
1,782
|
2,773
|
1,813
|
1,962
|
3,598
|
3,973
|
4,438
|
4,845
|
Net income
1 |
1,321
|
1,808
|
1,347
|
1,202
|
2,702
|
3,011
|
3,230
|
3,661
|
Net margin
|
1.77%
|
1.63%
|
1.07%
|
0.83%
|
1.75%
|
2.05%
|
2.24%
|
2.26%
|
EPS
2 |
3.140
|
3.120
|
2.280
|
2.070
|
4.950
|
5.753
|
6.496
|
7.585
|
Free Cash Flow
1 |
753
|
4,634
|
3,295
|
5,257
|
7,254
|
4,270
|
4,344
|
4,348
|
FCF margin
|
1.01%
|
4.17%
|
2.62%
|
3.64%
|
4.71%
|
2.91%
|
3.01%
|
2.68%
|
FCF Conversion (EBITDA)
|
26.9%
|
93.2%
|
60.02%
|
113.69%
|
132.49%
|
92.2%
|
88.13%
|
80.49%
|
FCF Conversion (Net income)
|
57%
|
256.31%
|
244.62%
|
437.35%
|
268.47%
|
141.85%
|
134.49%
|
118.76%
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
1.667
|
-
|
Announcement Date
|
2/4/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
32,406
|
32,568
|
37,185
|
35,936
|
35,865
|
35,561
|
38,889
|
37,608
|
38,042
|
39,460
|
40,407
|
36,370
|
36,286
|
36,884
|
38,609
|
EBITDA
1 |
991
|
1,062
|
1,742
|
1,735
|
1,156
|
472
|
1,534
|
1,528
|
1,541
|
434
|
1,376
|
1,409
|
1,241
|
514.7
|
1,588
|
EBIT
1 |
808
|
684
|
1,551
|
1,537
|
976
|
305
|
1,371
|
1,382
|
1,393
|
119
|
1,241
|
1,222
|
1,081
|
423.9
|
1,432
|
Operating Margin
|
2.49%
|
2.1%
|
4.17%
|
4.28%
|
2.72%
|
0.86%
|
3.53%
|
3.67%
|
3.66%
|
0.3%
|
3.07%
|
3.36%
|
2.98%
|
1.15%
|
3.71%
|
Earnings before Tax (EBT)
1 |
720
|
694
|
1,148
|
-236
|
1,009
|
41
|
1,391
|
1,415
|
768
|
24
|
1,473
|
1,263
|
1,143
|
349.5
|
1,482
|
Net income
1 |
584
|
599
|
849
|
-172
|
738
|
-213
|
1,130
|
1,058
|
469
|
45
|
1,163
|
897.1
|
833.3
|
220.7
|
1,087
|
Net margin
|
1.8%
|
1.84%
|
2.28%
|
-0.48%
|
2.06%
|
-0.6%
|
2.91%
|
2.81%
|
1.23%
|
0.11%
|
2.88%
|
2.47%
|
2.3%
|
0.6%
|
2.82%
|
EPS
2 |
0.9900
|
1.010
|
1.440
|
-0.2900
|
1.270
|
-0.3800
|
2.040
|
1.920
|
0.8700
|
0.0800
|
2.160
|
1.726
|
1.641
|
0.4612
|
2.108
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/26/21
|
2/8/22
|
4/26/22
|
7/26/22
|
10/25/22
|
2/7/23
|
4/25/23
|
7/28/23
|
10/24/23
|
2/6/24
|
4/26/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,603
|
5,979
|
5,720
|
5,946
|
636
|
1,716
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
1,239
|
4,636
|
Leverage (Debt/EBITDA)
|
0.5727
x
|
1.203
x
|
1.042
x
|
1.286
x
|
0.1162
x
|
0.3704
x
|
-
|
-
|
Free Cash Flow
1 |
753
|
4,634
|
3,295
|
5,257
|
7,254
|
4,271
|
4,344
|
4,348
|
ROE (net income / shareholders' equity)
|
15.8%
|
15.1%
|
5.12%
|
13.2%
|
14.6%
|
13.7%
|
14.1%
|
14.3%
|
ROA (Net income/ Total Assets)
|
5.17%
|
3.3%
|
1.83%
|
4.33%
|
4.51%
|
4.04%
|
4.28%
|
4.27%
|
Assets
1 |
25,572
|
54,857
|
73,547
|
27,752
|
59,846
|
74,557
|
75,507
|
85,693
|
Book Value Per Share
2 |
30.20
|
44.30
|
46.00
|
43.70
|
48.30
|
51.00
|
57.10
|
61.50
|
Cash Flow per Share
2 |
3.530
|
9.500
|
7.120
|
10.80
|
14.80
|
5.550
|
11.40
|
-
|
Capex
1 |
730
|
869
|
910
|
1,004
|
799
|
758
|
835
|
875
|
Capex / Sales
|
0.98%
|
0.78%
|
0.72%
|
0.69%
|
0.52%
|
0.52%
|
0.58%
|
0.54%
|
Announcement Date
|
2/4/20
|
2/9/21
|
2/8/22
|
2/7/23
|
2/6/24
|
-
|
-
|
-
|
Average target price
88.72
USD Spread / Average Target +19.90% Consensus |
1st Jan change
|
Capi.
|
---|
| -0.28% | 39.69B | | +13.93% | 125B | | +18.37% | 101B | | -33.18% | 36.86B | | -5.28% | 20.05B | | -13.82% | 3.08B | | -39.49% | 993M | | -28.58% | 337M |
Other Managed Healthcare
|